🔎 Trials Near Me

መነሻ › ሜላኖማ › Pennsylvania › Pittsburgh

በPittsburgh፣ PA ለሜላኖማ የሚደረጉ ክሊኒካዊ ጥናቶች

ለሜላኖማ የሚደረጉ 31 ጥናቶች በPittsburgh እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Allegheny Health Network, Pittsburgh
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT05727904

A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07621614

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 75 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ24 ሴፕቴ 2026 · NCT07068074

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ15 ሴፕቴ 2026 · NCT04511013

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh Medical Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ሴፕቴ 2026 · NCT07070232

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ኦገስ 2026 · NCT05896839

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
12 Months – 30 Years · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT04851119

Project: Every Child for Younger Patients With Cancer

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Children's Hospital of Pittsburgh of UPMC, Pittsburgh
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ኦገስ 2026 · NCT02402244

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Research Site, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ኦገስ 2026 · NCT07115043

Investigating Real-Time Immunotherapy Symptoms Study

ተሳታዮችን በመፈለግ ላይ
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07280715

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • Allegheny Research Institute (Melanoma/NSCLC), Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ጁላይ 2026 · NCT06060613

Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ23 ጁን 2026 · NCT04114136

A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ ከ18 እስከ 70 · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT05361174

Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ጁን 2026 · NCT04658303

Evaluation of Hypoxia in Primary Melanoma

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT06831071

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ10 ጁን 2026 · NCT05655312

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh Medical Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ሜይ 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ6 ሜይ 2026 · NCT07015190

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh Medical Center - Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ኤፕሪ 2026 · NCT06413680

A Study to Investigate the Safety and Efficacy of NST-628 Oral Tablets in Subjects With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ኤፕሪ 2026 · NCT06326411

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ16 ኤፕሪ 2026 · NCT07223424

RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis

ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ13 ኤፕሪ 2026 · NCT06216938

A Study of VET3-TGI in Patients With Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1
  • UPMC- Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ7 ኤፕሪ 2026 · NCT06444815

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • UPMC Hillman Cancer Center, Pittsburgh
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኤፕሪ 2026 · NCT06581406

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ፌብሩ 2026 · NCT05549297

Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ26 ጃንዩ 2026 · NCT06599619

Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh Medical Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ29 ኦክቶ 2025 · NCT06249048

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh Medical Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ኦክቶ 2025 · NCT04370587

A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • UPMC Hillman Cancer Center, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2025 · NCT05970497

Safety, Tolerability, and Preliminary Efficacy of CJRB-101 With Pembrolizumab in Subjects With Selected Types of Advanced or Metastatic Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 1/2
  • University of Pittsburgh, Pittsburgh
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ20 ዲሴም 2024 · NCT05877430

በሌሎች ከተሞች ለሜላኖማ የሚደረጉ ጥናቶች

በPittsburgh ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።